May 2016 FDA Recall Drug by Par Pharmaceutical
D-1038-2016 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Par Pharmaceutical on May 28, 2016 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1038-2016

Reason for Recall
Failed Impurities/Degradation Specifications: Par Pharmaceutical is recalling Pramipexole Dihydrochloride Extended Release tablets because it contains a known product impurity above currently approved specification levels.
Initiated
05-28-2016
Reported
06-22-2016
Quantity
12,535 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Nationwide and Puerto Rico.
Pramipexole Dihydrochloride Extended Release Tablets, 0.375 mg, Rx Only, 30 count bottles, Manufactured By: Par Pharmaceutical Companies, Inc., Chestnut Ridge, NY 10977, NDC 10370-251-11

Batch or Lot Expiration Information

Lot# s: 27409201, 27409301, 27409401, Exp. 02/2017; 27662101, Exp. 07/2017